STK11 and adenocarcinoma: Inactivating LKB1/STK11 germline mutations in combination with loss of the wild-type allele by chromosomal loss or methylation are responsible for the development of hamartomatous polyps and adenocarcinomas in Peutz–Jeghers syndrome patients.